<DOC>
	<DOC>NCT01165346</DOC>
	<brief_summary>Stereotaxic radiation by CyberKnife : 3 X 15 Gy over 8 to 10 days for a total of 45 Gy.</brief_summary>
	<brief_title>Stereotaxic Irradiation of Hepatocellular Carcinoma</brief_title>
	<detailed_description>Stereotaxic radiation by CyberKnife : 3 X 15 Gy over 8 to 10 days for a total of 45 Gy</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<criteria>Primitive liver cancer (hepatocellular carcinoma), proved by histology or diagnostic according to BCLC criteria T13 N0 M0 With only one intra hepatic lesion and dimensions between 1 cm and 6 cm (IRM or hepatic scanner) Stereotaxic radiotherapy treatment approved in multidisciplinary consultation, the patient being rejected for standard therapeutic Age &gt;= 18 ans Previous anti tumoral treatment allowed but suspended since at least 15 days before the inclusion OMS =&lt; 2 Portal thrombosis allowed Portal high blood pressure allowed No contraindication of fiducials implantation, hemostasis disorders must be treated before the implantation In case of underlying cirrhosis, only the ChildPugh A is allowed Life expectancy &gt;= 12 weeks Women must have an active contraception during all the study Patient affiliated to health insurance Patient must sign the consent T4 Cirrhosis Child B and C Hepatic lesion &lt; 1 cm or &gt; 6 cm 2 hepatic lesions or more Recurrent or metastatic disease Patient already included in another therapeutic trial with an experimental molecule Allergy to gold Pregnant women or susceptible to be pregnant or breastfeeding Unable for medical followup (geographic, social or mental reasons)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>liver cancer</keyword>
	<keyword>hepatocellular carcinoma</keyword>
</DOC>